What is the future of CLOV stock?
Stock Price Forecast The 6 analysts offering 12-month price forecasts for Clover Health Investments Corp have a median target of 3.25, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +4.84% increase from the last price of 3.10.
Should I hold CLOV stock?
The consensus among Wall Street analysts is that investors should "hold" Clover Health Investments stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
Is CLOV a hold?
Out of 5 analysts, 1 (20%) are recommending CLOV as a Strong Buy, 0 (0%) are recommending CLOV as a Buy, 3 (60%) are recommending CLOV as a Hold, 1 (20%) are recommending CLOV as a Sell, and 0 (0%) are recommending CLOV as a Strong Sell. What is CLOV's earnings growth forecast for 2022-2024?
Is CLOV stock overvalued?
Although there was a lot of excitement about the shares due to the company's asset-light model and Clover Assistant, its web-based platform used by physicians to manage and analyze patient data, CLOV stock became overvalued due to retail investors' enthusiasm and hype.Aug 10, 2021
Why is CLOV dropping?
Known as the “king of SPACs,” Clover saw its stock price plummet earlier this year. The likely culprit: research firm Hindenburg shorted the stock, claiming that the company was the target of an investigation for dubious sales practices.Dec 2, 2021
Does Citadel own CLOV?
2022-02-14 - Citadel Advisors Llc has filed a 13F-HR form disclosing ownership of 3,589,146 shares of Clover Health Investments Corp Class A (US:CLOV) with total holdings valued at $13,352,000 USD as of 2021-12-31.
Why is CLOV stock up?
Right now, CLOV stock is up in response to Clinton's purchase, which investors are viewing as a positive signal. Often times, director trading activity like this is important to track because insiders often have a better view of a company's long-term growth potential than retail investors.Mar 7, 2022
What is Nio price target?
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.97, with a high estimate of 86.67 and a low estimate of 24.11.
Will clover stock recover?
Clover Health stumbled out of the gate. It failed to disclose a government investigation into its business. Shares dropped by nearly half as short sellers revealed that fact. Subsequently, Clover has failed to recover.Feb 8, 2022
Is CLOV profitable?
CLOV earnings show improving profitability and promising 2022 guidance. Q4 results carry some evidence that CLOV's profitability issues were temporary. At current prices, the company is undervalued, despite its above-average growth.Feb 25, 2022
What is the current short interest on CLOV?
Clover Health Investments currently has a short interest ratio of 2.0. Learn More on Clover Health Investments's short interest ratio.
How do you find out if a stock is being shorted?
For general shorting information about a company's stock, you can usually go to any website with a stock quote service. For more specific short interest info, you would have to go to the stock exchange where the company is listed.
Is Clover Health Investments a buy right now?
8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are cu...
When is Clover Health Investments' next earnings date?
Clover Health Investments is scheduled to release its next quarterly earnings announcement on Monday, May 16th 2022. View our earnings forecast fo...
What guidance has Clover Health Investments issued on next quarter's earnings?
Clover Health Investments updated its FY 2022 earnings guidance on Wednesday, March, 16th. The company provided earnings per share guidance of for...
What price target have analysts set for CLOV?
8 equities research analysts have issued 1-year price objectives for Clover Health Investments' stock. Their forecasts range from $2.50 to $10.00....
Who are Clover Health Investments' key executives?
Clover Health Investments' management team includes the following people: Mr. Vivek Garipalli , Co-Founder, CEO & Chairman of Directors (Age 42)...
Who are some of Clover Health Investments' key competitors?
Some companies that are related to Clover Health Investments include UnitedHealth Group (UNH) , Anthem (ANTM) , Cigna (CI) , Humana (HUM) , Ce...
What is Clover Health Investments' stock symbol?
Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."
Who are Clover Health Investments' major shareholders?
Clover Health Investments' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford...
Which institutional investors are selling Clover Health Investments stock?
CLOV stock was sold by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, IMC Chicago LLC, Ci...